- Congresses
- IMCAS Americas - April 2025
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Americas - April 2025
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Congress map
Accreditation

GO BACK

IMCAS World Congress 2024
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC+02:00) Europe, Paris

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

219

CHAMEDITECH Symposium - How to make the skin glow with soft injection

Room: Room 252 - Level 2
Date: Saturday 3 February 2024 at 14:00 to 15:30
Format: INDUSTRY SYMPOSIUM > educational and promotional program conducted by the supporting company

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
14:00	Dr Huray HUGUL	New era illumination and antiaging protocol	View	135139
14:45	Dr Jose Ramon VAZQUEZ CASAS	IFRHA® Methodology (Isovolumetric facial replacement of Hyaluronic Acid)	View	135140

Go to previous session

Go to next session

Recommended sessions

Fillers: HA (hyaluronic acid)

Dr Huray HUGUL

Dermatologist

Turkey

Other author(s) :

New era illumination and antiaging protocol

Objectives: Our aim is evaluating weakly cross linked hyaluronic acid transparent gel-type product ''Dorothy'' in our patients facial and neck skin areas rejuvenation. This product is a colourless transparent gel-type product with viscoelasticity composed of a stabilized non-animal hyaluronic acid.

Introduction: We have evaluated 1 male and 8 female totally 9 patients with Dorothy. We have measured their skin quality; thickness, pores, sebum distrubition, UV damage, UV pigmentation, telangiectasias, wrinkle distribution, moisture ratio, sensitive areas and the age of skin with a dermatological skin quality measuring equipment ''pHFormula Machine'' before the treatment and after the treatment.

Materials / method: We have contributed 9 patients to this study. 1 male and 8 female. (The M/F ratio is 1/8). We have applied 6 patients whole the 9 ml hyaluronic acid enjections at one session. 9 ML PROCEDURE (at one session) We have applied 3 patients; hyaluronic acid enjection at two to three sessions. POLYSHOT PROCEDURE (more than 1 session). The ratio of 9 ML PROCEDURE/POLYSHOT PROCEDURE is %66,6.

Results: Hyaluronic acid is used for facial tissue augmentation into areas in which restoration is required also helps to improve the skin quality. 9 ML PROCEDURE was significantly more effective than POLYSHOT PROCEDURE in skin improvement, wrinkle reduction, decreasing UV damage and UV hyperpigmentation.

Conclusion: We know that hyaluronic acid is used for facial tissue augmentation into areas in which restoration is required also helps to improve the skin quality. Our study has shown that 9 ML PROCEDURE was significantly more effective than POLYSHOT PROCEDURE in skin improvement, wrinkle reduction, decreasing UV damage and UV hyperpigmentation.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: CHAMEDITECH

Dr Jose Ramon VAZQUEZ CASAS

Internal medicine

Spain

Other author(s) :

IFRHA® Methodology (Isovolumetric facial replacement of Hyaluronic Acid)

Objectives: The objective of the implementation of the IFRHA® methodology is to replace this synthesis deficit locally with very high doses of HA, with a hydrobooster that does not generate volume or changes in facial structure.

Introduction: The synthesis capacity of hyaluronic acid (HA) decreases throughout the life of a human being, which leads to morphological and functional changes in our skin. This decrease in its synthesis is much more evident in specific periods of life. One of these periods where this process is accelerated is the peri- and postmenopausal period of women, where the decrease in estrogen receptors and levels (much more evident in facial skin), causes very rapid changes in the quality of the skin: decreased skin thickness, atrophy, loss of elasticity, dehydration and increased the wrinkles.

Materials / method: A descriptive observational cohort study was carried out on 15 female patients over 50 years of age, where the safety and efficacy of intradermal injection with high dose at the facial level of a hydrobooster with minimally cross-linked HA (Dorothy®) has been evaluated. Using a fan and linear threading technique, 2 sessions were carried out separated by 1 month and the results were assessed 3 months after the first session. A photographic study was carried out, a sample of the basic skin parameters was taken with a probe and the pain scale and the degree of patient satisfaction were recorded.

Results: The results obtained with intradermotherapy with high doses of a hydrobooster such as Dorothy®, have been able to demonstrate the high effectiveness of this procedure, with significant improvement in all the basic parameters of the skin, being a safe procedure, very minimally invasive and with minimal side effects. All patients reported a high degree of satisfaction.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS China
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS World Congress 2024 Program

219

CHAMEDITECH Symposium - How to make the skin glow with soft injection

Lectures of the session

Recommended sessions

IMCAS World Congress 2024
Program